Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Allwinn

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Medical Microbiology and Immunology|November 30, 2002
The "influenza vaccine"--benefit, risk, costsR Allwinn, H W Doerr
Deutsche Medizinische Wochenschrift (1946)|November 4, 2011
[Comparison of seasonal influenza vaccines: composition and properties]R Allwinn, H W Doerr
Deutsche Medizinische Wochenschrift (1946)|April 7, 2005
[Is avian influenza a risk for humans?]R Allwinn, H W Doerr
Wiener Medizinische Wochenschrift (1946)|January 1, 1997
[Viral exanthematic childhood diseases]R Allwinn, H W Doerr
Infection|March 23, 2011
Limited prevalence of influenza A/H1N1v antibodies: footprints of the pandemic of 2010C Reinheimer, R Allwinn, H W Doerr
MMW Fortschritte Der Medizin|August 14, 2001
[Study of vaccination for travel shows: serious gaps in polio, diphtheria and tetanus vaccination]B Ludwig, H W Doerr, R Allwinn
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1995
Influence of free or liposomal amphotericin B on killing of Candida species by human peritoneal macrophagesR Allwinn, R Schaumann, P M Shah
Deutsche Medizinische Wochenschrift (1946)|January 20, 2012
[Measles: immunity and vaccination status in Greater Frankfurt on the Main]I Friedrichs, H W Doerr, R Allwinn
Deutsche Medizinische Wochenschrift (1946)|December 26, 2001
[Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox]S Buxbaum, H W Doerr, R Allwinn
Infection|June 18, 2010
Seroepidemiology of parvovirus B19 in the Frankfurt am Main area, Germany: evaluation of risk factorsC Reinheimer, R Allwinn, H W Doerr, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Medical Microbiology and Immunology|November 30, 2002
The "influenza vaccine"--benefit, risk, costsR Allwinn, H W Doerr
Deutsche Medizinische Wochenschrift (1946)|November 4, 2011
[Comparison of seasonal influenza vaccines: composition and properties]R Allwinn, H W Doerr
Deutsche Medizinische Wochenschrift (1946)|April 7, 2005
[Is avian influenza a risk for humans?]R Allwinn, H W Doerr
Wiener Medizinische Wochenschrift (1946)|January 1, 1997
[Viral exanthematic childhood diseases]R Allwinn, H W Doerr
Infection|March 23, 2011
Limited prevalence of influenza A/H1N1v antibodies: footprints of the pandemic of 2010C Reinheimer, R Allwinn, H W Doerr
MMW Fortschritte Der Medizin|August 14, 2001
[Study of vaccination for travel shows: serious gaps in polio, diphtheria and tetanus vaccination]B Ludwig, H W Doerr, R Allwinn
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1995
Influence of free or liposomal amphotericin B on killing of Candida species by human peritoneal macrophagesR Allwinn, R Schaumann, P M Shah
Deutsche Medizinische Wochenschrift (1946)|January 20, 2012
[Measles: immunity and vaccination status in Greater Frankfurt on the Main]I Friedrichs, H W Doerr, R Allwinn
Deutsche Medizinische Wochenschrift (1946)|December 26, 2001
[Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox]S Buxbaum, H W Doerr, R Allwinn
Infection|June 18, 2010
Seroepidemiology of parvovirus B19 in the Frankfurt am Main area, Germany: evaluation of risk factorsC Reinheimer, R Allwinn, H W Doerr, et al.
Pageof 3